Search Results - "REBEYKA, I"

Refine Results
  1. 1

    Discarded Human Thymus Is a Novel Source of Stable and Long‐Lived Therapeutic Regulatory T Cells by Dijke, I. E., Hoeppli, R. E., Ellis, T., Pearcey, J., Huang, Q., McMurchy, A. N., Boer, K., Peeters, A. M. A., Aubert, G., Larsen, I., Ross, D. B., Rebeyka, I., Campbell, A., Baan, C. C., Levings, M. K., West, L. J.

    Published in American journal of transplantation (01-01-2016)
    “…Regulatory T cell (Treg)–based therapy is a promising approach to treat many immune‐mediated disorders such as autoimmune diseases, organ transplant rejection,…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Human Leukocyte Antigen (HLA) Class II Expression on Regulatory T Cells (Tregs) Isolated from Discarded Human Thymus is Induced by In Vitro Expansion Conditions by Dijke, E., Ellis, T., Larsen, I., Rebeyka, I., Freed, D., Al-Aklabi, M., Levings, M., West, L.

    “…Tregs modulate immune responses and are a promising therapeutic tool to limit graft rejection in organ transplantation. We showed that potent Tregs can be…”
    Get full text
    Journal Article
  4. 4

    Real-Time 3-Dimensional Echocardiography Provides New Insight Into Mechanisms of Tricuspid Valve Regurgitation in Patients With Hypoplastic Left Heart Syndrome by TAKAHASHI, K, INAGE, A, REBEYKA, I. M, ROSS, D. B, THOMPSON, R. B, MACKIE, A. S, SMALLHORN, J. F

    Published in Circulation (New York, N.Y.) (22-09-2009)
    “…Tricuspid regurgitation in hypoplastic left heart syndrome has an impact on outcome, but its mechanisms remain unclear. Real-time 3-dimensional…”
    Get full text
    Journal Article
  5. 5

    Successful Semi‐Ambulatory Veno‐Arterial Extracorporeal Membrane Oxygenation Bridge to Heart–Lung Transplantation in a Very Small Child by Wong, J. Y. W., Buchholz, H., Ryerson, L., Conradi, A., Adatia, I., Dyck, J., Rebeyka, I., Lien, D., Mullen, J.

    Published in American journal of transplantation (01-08-2015)
    “…Lung transplantation (LTx) may be denied for children on extracorporeal membrane oxygenation (ECMO) due to high risk of cerebral hemorrhage. Rarely has…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Pediatric Thymic Tissue as a Source of Regulatory T Cells for Cellular Therapy by Dijke, E, McMurchy, A, Levings, M, Larsen, I, Rebeyka, I, Ross, D, West, L

    “…Purpose Infant heart transplant (HTx) recipients have better graft survival than older recipients. Nonetheless, due to need for lifelong therapy, infants carry…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Multicenter Canadian Experience with the HeartWare HVAD by Rao, V, Legare, J.F, Mac Arthur, R, Bashir, J, Freed, D, Cheung, A, Baskett, R, Mullen, J, Rebeyka, I, Yau, T, Cusimano, R.J

    “…Purpose The HeartWare HVAD is a third generation centrifugal pump that has recently completed a US bridge to transplant clinical trial. The device is available…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    ABO-Incompatible Heart Transplantation in Infants by West, Lori J, Pollock-Barziv, Stacey M, Dipchand, Anne I, Lee, K. Jin, Cardella, Carl J, Benson, Leland N, Rebeyka, Ivan M, Coles, John G

    Published in The New England journal of medicine (15-03-2001)
    “…Solid-organ transplantation between donors and recipients with incompatible blood groups is usually contraindicated because of the high risk of hyperacute…”
    Get full text
    Journal Article